期刊文献+

帕金森病的血生物学指标研究进展

Advances in the Study on the Blood Biomarkers of Parkinson's Disease
下载PDF
导出
摘要 帕金森病以黑质多巴胺能神经元变性、缺失和路易小体形成为病理特征,其发生机制与黑质纹状体系统氧化应激反应增强、自由基增多损害多巴胺能神经元等密切相关。研究发现尿酸、8-羟基脱氧鸟苷、谷胱甘肽、铁和白介素-6等血生物学指标在帕金森病患者发生了有意义的变化,本文就此作一综述。 Parkinson' s disease (PD) is a common neurodegenerative disorder, characterized by progressive degeneration of the dopaminergic neurons in the substantia nigra pars compacta (SNpc) and generation of Lewy body. The exact mechanisms remain unknown. However oxidative stress and free radical are generally thought to play a prominent role in the etiology of PD. Several studies suggest that uric acid, 8 - hydroxy - 2'- deoxyguanosine, glutathione, iron, interleukin - 6 and other biomarkers of blood in PD patients have been significantly changed.
出处 《国际老年医学杂志》 2011年第4期161-165,共5页 International Journal of Geriatrics
基金 江苏省自然科学基金项目(BK2010229)江苏省高校自然研究计划项目(08KJB320012)苏州市科技发展计划(社会发展及医药)资助项目(200815404)
关键词 帕金森病 生物学指标 研究进展 Parkinson' s disease Biomarkers Research
  • 相关文献

参考文献30

  • 1Weisskopf MG, Ol~eilly E, Chen H, et al. Plasma u- rate and risk of Parkinson's disease [ J]. Am Epidemi- ol, 2007, 166 (5): 561-567.
  • 2Huang YX, Luo WF. Potential role of uric acid as a biomarker for Parkinson'ss disease [ J ]. Med Hypothe-ses, 2010, 75 (2): 273.
  • 3Gao X, Chen H, Choi HK, et al. Diet, urate and Parkinsong disease risk in men [ J ]. Am Epidemiol, 2008, 167 (7): 831-838.
  • 4de Lau LM, Koudstaal PJ, Hofman A, et al. Serum uric acid levels and the risk of Parkinson disease [ J]. Ann Neurol, 2005, 58 (5): 797-800.
  • 5De Vera M, Rahman MM, Rankin J, et al. Gout and the risk of Parkinson′s disease: a cohort study [ J ]. Ar- thritis Rheum, 2008, 59 (11): 1549-1554.
  • 6Alonso A, Rodriguez LA, Logroscino G, et al. Gout and risk of Parkinson disease: a prospective study [J]. Neurology, 2007, 69 (17): 1696-1700.
  • 7罗蔚锋,王丽君,王晓君,王恒会,毛成洁,刘春风.老年男性帕金森病患者血尿酸水平的研究[J].中华老年医学杂志,2009,28(1):60-61. 被引量:6
  • 8Annanmaki T, Muuronen A, Murros K. Low plasma uric acid level in Parkinson' s disease [J]. Mov Dis- ord, 2007, 22 (8): 1133-1137.
  • 9王丽君,罗蔚锋,王恒会,刘春风.帕金森病患者血尿酸水平[J].中华神经科杂志,2008,41(3):157-158. 被引量:28
  • 10王晓君,罗蔚锋,王丽君,毛成洁,王兰,刘春风.帕金森病患者认知功能与尿酸及相关因素分析[J].中华医学杂志,2009,89(23):1633-1635. 被引量:32

二级参考文献39

  • 1蔡晓杰,陈海波,王新德,贡慧华.帕金森病患者的智能障碍—瑞文测验的应用及意义[J].脑与神经疾病杂志,1997,5(2):94-96. 被引量:13
  • 2Jenner P. Oxidative stress in Parkinson' s disease. Ann Neural, 2003,53 Suppl 3 :S26-S38.
  • 3Hink HU, Santanam N, Dikalov S, et al. Peroxidase properties of extraceUular superoxide dismutase:role of uric acid in modulating in vivo activity. Arterioscler Thromb Vasc Biol, 2002,22 : 1402- 1408.
  • 4Duan W, Ladenheim B, Cutler RG, et al. Dietary folate deficiency and elevated homocysteine levels endanger dopaminergic neurons in models of Parkinson' s disease. J Neurochem, 2002, 80 : 101-110.
  • 5Fitzmaurice PS, Ang L, Guttman M, et al. Nigral glutathione deficiency is not specific for idiopathic Parkinson' s disease. Mov Disord, 2003,18:969-976.
  • 6Meara J, Bhowmick BK, Hobson P. Accuracy of diagnosis in patients with presumed Parkinson' s disease. Age Ageing, 1999, 28 : 99-102.
  • 7Church WH,Ward VL Uric acid is reduced in the substantia nigra in Parkinsen' s disease: effect on dopamine oxidation. Brain Res Bull,1994, 33: 419-425.
  • 8Kim TS, Pae CU, Yoon SJ, et al. Decreased plasma antioxidants in patients with Alzheimer' s disease. Int J Geriatr Psychiatry, 2006,21:344-348.
  • 9Rentzos M, Nikolaou C, Anagnostouli M, et al. Serum uric acid and multiple sclerosis. Clin Neurol Neurosurg, 2006, 108 : 527- 531.
  • 10Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev, 2007,87:315-424.

共引文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部